@article{bd797aadb7024c5f986e309a9f80aab3,
title = "Long-Term Safety and Tolerability of Dasiglucagon, a Stable-in-Solution Glucagon Analogue",
author = "Castle, {Jessica R.} and Mikael Elander",
note = "Funding Information: J.R.C. has received honorarium from Zealand Pharma (advisory boards), Novo Nordisk (advisory boards), and Dexcom Inc (consulting), and she has received research funding from Xeris Pharmaceuticals. M.E. is an employee of Zealand Pharma.",
year = "2019",
month = feb,
doi = "10.1089/dia.2018.0363",
language = "English (US)",
volume = "21",
pages = "94--96",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "2",
}